Emixustat Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEmixustat Hydrochloride
Drug Alias NameEmixustat HCl艾米司他emixustatum依舒司他emixustat +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid isomerohydrolase inhibitors
TargetsRetinoid isomerohydrolase
Therapy Area/IndicationsAnetodermaGeographic AtrophyMacular Degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[11] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcucela Inc
China Registration ClassN/A

Develop Information

Active CompaniesKubota Vision Inc
Inactive CompaniesOtsuka Pharmaceutical Co Ltd
Active IndicationsStargardt Disease
Inactive IndicationsAnetodermaGeographic AtrophyMacular Degeneration +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG